| scholarly article | Q13442814 |
| P50 | author | Nikolaos G Frangogiannis | Q56899107 |
| P2093 | author name string | Nikolaos G Frangogiannis | |
| P2860 | cites work | Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling | Q24300680 |
| IRAK-M is a negative regulator of Toll-like receptor signaling | Q24302640 | ||
| The inflammasomes | Q24304087 | ||
| Inhibition of Stat1-mediated gene activation by PIAS1 | Q24310082 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions | Q24648717 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
| Th17 and regulatory T cells in mediating and restraining inflammation | Q27687428 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| CD44: from adhesion molecules to signalling regulators | Q28201701 | ||
| Regulation of immune responses by TGF-beta | Q28271433 | ||
| Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
| Resolution of lung inflammation by CD44 | Q28506254 | ||
| Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC) | Q28587215 | ||
| Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice | Q28594495 | ||
| Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 | Q28611075 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
| The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | Q29615381 | ||
| Nonresolving inflammation | Q29616352 | ||
| Regulatory T cells and immune tolerance | Q29616864 | ||
| Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin | Q30485290 | ||
| Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice | Q31949951 | ||
| Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice | Q33181525 | ||
| Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products | Q33190406 | ||
| The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury | Q33231048 | ||
| Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated | Q33656926 | ||
| Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? | Q33683210 | ||
| SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. | Q50335840 | ||
| The role of platelet-derived growth factor signaling in healing myocardial infarcts. | Q50712137 | ||
| Connective tissue growth factor and cardiac fibrosis after myocardial infarction. | Q50763650 | ||
| Regulation of leukocyte recruitment by the long pentraxin PTX3. | Q51774594 | ||
| CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. | Q52563229 | ||
| Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. | Q52583103 | ||
| Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury. | Q52901073 | ||
| Resolvin D series and protectin D1 mitigate acute kidney injury. | Q53592223 | ||
| Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. | Q53708193 | ||
| Novel aspects in the regulation of the leukocyte adhesion cascade. | Q55617999 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice | Q58807888 | ||
| Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages | Q61632775 | ||
| High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart | Q63384080 | ||
| Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1 | Q67680549 | ||
| Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta | Q67942705 | ||
| Transforming growth factor-beta 1 bifunctionally regulates murine macrophage proliferation | Q68054468 | ||
| Mediation of cardioprotection by transforming growth factor-beta | Q68467347 | ||
| Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction | Q69054767 | ||
| VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis | Q71800643 | ||
| Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion | Q73047639 | ||
| Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury | Q73514253 | ||
| Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis | Q73959004 | ||
| IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury | Q74183226 | ||
| Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice | Q77649728 | ||
| The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes | Q79954986 | ||
| Chemokines in ischemia and reperfusion | Q80265485 | ||
| CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response | Q80633666 | ||
| Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction | Q80987635 | ||
| Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts | Q81802458 | ||
| Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody | Q82307930 | ||
| Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury | Q83333586 | ||
| Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction | Q84160126 | ||
| Immunobiology of the TAM receptors | Q33796991 | ||
| CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells | Q33816303 | ||
| Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion | Q33853630 | ||
| Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling | Q33862454 | ||
| Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. | Q33916695 | ||
| Targeting C-reactive protein for the treatment of cardiovascular disease. | Q33995386 | ||
| Cellular and molecular basis for the regulation of inflammation by TGF-beta | Q34028060 | ||
| Lymphocyte traffic control by chemokines | Q34139610 | ||
| Prostaglandins and inflammation | Q34179727 | ||
| Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. | Q34184675 | ||
| Predictors of late development of heart failure in stable survivors of myocardial infarction | Q34270587 | ||
| RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation | Q34311133 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| The chemokine receptor D6 limits the inflammatory response in vivo | Q34400531 | ||
| Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 | ||
| Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. | Q35083426 | ||
| Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression | Q35633812 | ||
| IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes | Q35766246 | ||
| Smad3 as a mediator of the fibrotic response | Q35779047 | ||
| TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing | Q35841836 | ||
| Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling | Q35901480 | ||
| Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction | Q35947836 | ||
| Negative regulation of cytokine and TLR signalings by SOCS and others | Q36231107 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| Transforming growth factor-beta: a key mediator of fibrosis | Q36239091 | ||
| Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
| CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation | Q36376179 | ||
| The role of TGF-beta signaling in myocardial infarction and cardiac remodeling | Q36655326 | ||
| Tuning inflammation and immunity by chemokine sequestration: decoys and more | Q36662451 | ||
| Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. | Q36734858 | ||
| The immune system and cardiac repair. | Q37096652 | ||
| Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 | ||
| When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction | Q37217884 | ||
| Inflammation in the course of early myocardial ischemia | Q37238694 | ||
| Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study | Q37301547 | ||
| IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. | Q37415365 | ||
| The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction | Q37561922 | ||
| Resolvins and protectins: natural pharmacophores for resolution biology | Q37708842 | ||
| The multiple roles of monocyte subsets in steady state and inflammation | Q37741022 | ||
| Phagocyte partnership during the onset and resolution of inflammation. | Q37760424 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Pentraxins in innate immunity: lessons from PTX3. | Q37777659 | ||
| Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. | Q37819144 | ||
| Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 | ||
| Multiple facets of NF-κB in the heart: to be or not to NF-κB. | Q37870038 | ||
| The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls | Q37870040 | ||
| Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia | Q38360880 | ||
| Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial | Q38400764 | ||
| Resolvin E1 protects the rat heart against reperfusion injury | Q39708381 | ||
| Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation | Q40594061 | ||
| Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta 1. | Q41098186 | ||
| Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction | Q41769718 | ||
| Transforming growth factor beta-1 in acute myocardial infarction in rats | Q41790607 | ||
| Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment | Q41807024 | ||
| Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells | Q42483121 | ||
| Deleterious effects of methylprednisolone in patients with myocardial infarction | Q43655917 | ||
| Morphological characteristics of the microvasculature in healing myocardial infarcts | Q43826822 | ||
| The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study | Q44182263 | ||
| MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. | Q44399913 | ||
| Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. | Q44938264 | ||
| Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). | Q44956453 | ||
| Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. | Q45879983 | ||
| Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure | Q45883186 | ||
| Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. | Q46661965 | ||
| Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial | Q46883862 | ||
| An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion | Q47334506 | ||
| Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy | Q47957724 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 159-173 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Regulation of the inflammatory response in cardiac repair | |
| P478 | volume | 110 |
| Q59808753 | (Re) Solving Repair After Myocardial Infarction |
| Q38775998 | 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI. |
| Q89529804 | A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction |
| Q42606317 | A MERry response after myocardial infarction |
| Q38656290 | A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling. |
| Q26827943 | A neonatal blueprint for cardiac regeneration |
| Q37692892 | A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse |
| Q49817469 | A review of Chinese herbal medicine for the treatment of chronic heart failure. |
| Q39165833 | A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers. |
| Q36769369 | Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress |
| Q49379171 | Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats. |
| Q41147116 | Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function. |
| Q36293533 | Acute inflammation stimulates a regenerative response in the neonatal mouse heart |
| Q52579249 | Adenosine Receptor-Mediated Cardioprotection-Current Limitations and Future Directions. |
| Q99234013 | Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice |
| Q41051610 | Advanced glycation end-product (AGE)-albumin from activated macrophage is critical in human mesenchymal stem cells survival and post-ischemic reperfusion injury |
| Q37685771 | Aggravated myocardial infarction-induced cardiac remodeling and heart failure in histamine-deficient mice. |
| Q55021973 | Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. |
| Q47137916 | Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice |
| Q41523938 | Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction |
| Q64389747 | Ataxia-Telangiectasia Mutated Kinase: Role in Myocardial Remodeling |
| Q44654874 | Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction |
| Q92105515 | BAOXIN Granules Protected Mouse Model With Elevated Afterload From Cardiac Hypertrophy by Suppressing Both Inflammatory Reaction and Collagen Deposition |
| Q53200230 | BMP protein-mediated crosstalk between inflammatory cells and human pluripotent stem cell-derived cardiomyocytes. |
| Q37289676 | Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice |
| Q49327061 | Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse. |
| Q52919290 | Big eater macrophages dominate inflammation resolution following myocardial infarction. |
| Q35471494 | Biomarkers: hopes and challenges in the path from discovery to clinical practice. |
| Q35874397 | Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction |
| Q36505013 | Bone marrow transplantation modulates tissue macrophage phenotype and enhances cardiac recovery after subsequent acute myocardial infarction |
| Q48904418 | Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. |
| Q48121704 | Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation. |
| Q38846401 | Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue? |
| Q52332852 | Cardiac (myo)fibroblasts modulate the migration of monocyte subsets. |
| Q89641851 | Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload |
| Q92191078 | Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes |
| Q50096393 | Cardiac Fibrosis: The Beneficial Effects of Exercise in Cardiac Fibrosis. |
| Q29248143 | Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver |
| Q47763392 | Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair |
| Q38764929 | Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo. |
| Q54196284 | Cardiac fibroblasts support cardiac inflammation in heart failure. |
| Q46090593 | Cardiac immune cell remodeling after myocardial infarction |
| Q48618003 | Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade. |
| Q37544973 | Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction |
| Q36160819 | Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction |
| Q54401828 | Cardioprotective effects of adipokine apelin on myocardial infarction. |
| Q41333298 | Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction |
| Q95277553 | Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy |
| Q42428121 | Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction |
| Q38365651 | Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages |
| Q38811208 | Cellular recruitment in myocardial ischaemia/reperfusion injury. |
| Q35823694 | Choroidal neovascularization is inhibited via an intraocular decrease of inflammatory cells in mice lacking complement component C3. |
| Q40138868 | Circulating Biomarkers to Identify Responders in Cardiac Cell therapy |
| Q41379852 | Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal. |
| Q42606337 | Contribution of extramedullary organs in myocardial inflammation and remodeling: does the spleen cause cardiac melancholy? |
| Q36198993 | Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair |
| Q42016510 | Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction |
| Q47638836 | Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction |
| Q37351145 | Could interferon-gamma be a therapeutic target for treating heart failure? |
| Q26766491 | Crosstalk between the heart and peripheral organs in heart failure |
| Q33861926 | Cyclovirobuxinum D suppresses lipopolysaccharide-induced inflammatory responses in murine macrophages in vitro by blocking JAK-STAT signaling pathway |
| Q47807574 | Day-night dependence of gene expression and inflammatory responses in the remodeling murine heart post-myocardial infarction |
| Q39999470 | Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients |
| Q35115045 | Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction. |
| Q35073104 | Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis |
| Q36522680 | Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction |
| Q37735014 | Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy |
| Q47704324 | Densification of Type I Collagen Matrices as a Model for Cardiac Fibrosis |
| Q28545083 | Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction |
| Q92069663 | Discoveries Interview: Prof. Nikolaos G. Frangogiannis on the cardiac injury and repair processes |
| Q34519386 | Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade |
| Q48660344 | Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury. |
| Q51123571 | ERBB signaling attenuates proinflammatory activation of nonclassical monocytes. |
| Q38690713 | Early immunomodulatory effects of implanted human perivascular stromal cells during bone formation. |
| Q45797174 | Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction. |
| Q45341410 | Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart |
| Q36435494 | Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. |
| Q28274305 | Endogenous modulators of inflammatory cell recruitment |
| Q37482793 | Endoplasmic reticulum stress in bone marrow-derived cells prevents acute cardiac inflammation and injury in response to angiotensin II. |
| Q46463805 | Engineering of an angiogenic niche by perfusion culture of adipose-derived stromal vascular fraction cells |
| Q37342782 | Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. |
| Q30355193 | Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction |
| Q39018712 | Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy |
| Q88453278 | Epigenetics of Aberrant Cardiac Wound Healing |
| Q74441761 | Escaped DNA inflames the heart |
| Q35462957 | Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling |
| Q92641576 | Expression of Leukocytes Following Myocardial Infarction in Rats is Modulated by Moderate White Wine Consumption |
| Q55344578 | Expression of adhesion molecules on granulocytes and monocytes following myocardial infarction in rats drinking white wine. |
| Q34336849 | Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction |
| Q59800422 | Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction |
| Q35034878 | Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure |
| Q38423857 | Extracellular matrix communication and turnover in cardiac physiology and pathology |
| Q36942196 | FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction |
| Q37716851 | Fibroblasts in myocardial infarction: a role in inflammation and repair |
| Q36522008 | Fibroblasts in post-infarction inflammation and cardiac repair. |
| Q36728608 | Fibrous scaffolds for building hearts and heart parts |
| Q39434474 | From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities |
| Q100990215 | GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3 |
| Q54314174 | Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways. |
| Q64107641 | Ginseng Berry Extract Rich in Phenolic Compounds Attenuates Oxidative Stress but not Cardiac Remodeling post Myocardial Infarction |
| Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
| Q89722972 | Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events |
| Q52609376 | Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. |
| Q92898904 | Hang on tight: reprogramming the cell with microstructural cues |
| Q93197900 | Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy |
| Q104473374 | Heart failure after myocardial infarction: incidence and predictors |
| Q38654054 | Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics |
| Q38860810 | Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival |
| Q26739723 | How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction |
| Q93349664 | How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways |
| Q54455328 | Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt. |
| Q58805767 | Hydrogen Sulfide Alleviates Acute Myocardial Ischemia Injury by Modulating Autophagy and Inflammation Response under Oxidative Stress |
| Q36638247 | Hydrogen Sulfide Recruits Macrophage Migration by Integrin β1-Src-FAK/Pyk2-Rac Pathway in Myocardial Infarction |
| Q47160162 | Hydrogen Sulfide Reduces Recruitment of CD11b+Gr-1+ Cells in Mice With Myocardial Infarction |
| Q37720537 | Hydrogen sulfide attenuates the recruitment of CD11b⁺Gr-1⁺ myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury |
| Q89776597 | Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells |
| Q58919824 | Hypoxia Immunity, Metabolism, and Hyperthermia |
| Q42776371 | IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. |
| Q92863084 | IL-10/STAT3/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole |
| Q52889697 | IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-α-induced apoptosis in steroid-induced osteonecrosis. |
| Q36990685 | Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction. |
| Q37383576 | Image-guided therapies for myocardial repair: concepts and practical implementation |
| Q38051997 | Imaging the healing murine myocardial infarct in vivo: ultrasound, magnetic resonance imaging and fluorescence molecular tomography |
| Q27010686 | Immune modulation of stem cells and regeneration |
| Q90712264 | Immune responses in cardiac repair and regeneration: a comparative point of view |
| Q58104007 | Immunomodulation by Exosomes in Myocardial Infarction |
| Q57162899 | Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition |
| Q34538722 | Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function |
| Q58123958 | Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury |
| Q92540859 | Impacts of exercise interventions on different diseases and organ functions in mice |
| Q33999700 | Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. |
| Q38626650 | Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction. |
| Q33874591 | Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice |
| Q26747421 | Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword |
| Q38560476 | Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. |
| Q38390454 | Inflammation in cardiac injury, repair and regeneration. |
| Q60306046 | Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction |
| Q38355385 | Inflammatory markers in ST-elevation acute myocardial infarction |
| Q38788685 | Inflammatory processes in cardiovascular disease: a route to targeted therapies |
| Q37118803 | Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4. |
| Q46608425 | Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury. |
| Q91799034 | Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery |
| Q38250327 | Innate immune receptors in heart failure: Side effect or potential therapeutic target? |
| Q37406111 | Integrating the myocardial matrix into heart failure recognition and management |
| Q38566665 | Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts |
| Q44980873 | Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse |
| Q38183314 | Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure |
| Q38423864 | Intracellular signaling of cardiac fibroblasts |
| Q39412555 | Is Cardioprotection Dead? |
| Q33688720 | It takes two to tango: monocyte and macrophage duality in the infarcted heart |
| Q39828591 | Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages |
| Q37342086 | Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis |
| Q34499585 | Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study |
| Q47580544 | Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury |
| Q33561481 | Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models |
| Q38667788 | Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling |
| Q100464597 | Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
| Q35194787 | Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction |
| Q41102448 | Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization |
| Q41887614 | Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure |
| Q33596007 | Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium |
| Q91690173 | Lymphocytic subsets play distinct roles in heart diseases |
| Q47128361 | MR Assessment of Acute Pathologic Process after Myocardial Infarction in a Permanent Ligation Mouse Model: Role of Magnetic Nanoparticle-Contrasted MRI. |
| Q94595715 | Macrophage Activities in Myocardial Infarction and Heart Failure |
| Q40361918 | Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury |
| Q89454243 | Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair |
| Q41472404 | Macrophages in the Remodeling Failing Heart |
| Q47773105 | Macrophages in the infarct: fiery friends or friendly fire? |
| Q36040528 | Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction |
| Q35102230 | Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice |
| Q39903739 | Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF. |
| Q36684243 | Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation |
| Q38224193 | Matrix metalloproteinases are involved in cardiovascular diseases |
| Q89862397 | Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer |
| Q49828823 | Mechanisms and Therapeutic Targets of Cardiac Regeneration: Closing the Age Gap. |
| Q38044254 | Mechanisms and consequences of inflammatory signaling in the myocardium |
| Q50066226 | Mechanisms of Fibroblast Activation in the Remodeling Myocardium. |
| Q98771706 | Mediastinal Lymphadenopathy, Class-Switched Auto-Antibodies and Myocardial Immune-Complexes During Heart Failure in Rodents and Humans |
| Q46076454 | Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction |
| Q33632033 | Membrane-associated matrix proteolysis and heart failure. |
| Q97520285 | Merging microarray studies to identify a common gene expression signature to several structural heart diseases |
| Q89807074 | Mesenchymal Stem Cells Promote the Resolution of Cardiac Inflammation After Ischemia Reperfusion Via Enhancing Efferocytosis of Neutrophils |
| Q47146529 | Mesenchymal Stem Cells in Cardiology |
| Q38175951 | Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. |
| Q64275072 | Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization |
| Q38915516 | MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40. |
| Q38161836 | MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. |
| Q36723373 | Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression |
| Q39334539 | Mitochondria in Structural and Functional Cardiac Remodeling |
| Q38788603 | Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models. |
| Q39027005 | Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease |
| Q34999159 | Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats |
| Q47122950 | Molecular and histological effects of MR-guided pulsed focused ultrasound to the rat heart |
| Q55365025 | Molecular signature of progenitor cells isolated from young and adult human hearts. |
| Q36840151 | Monocyte and macrophage contributions to cardiac remodeling. |
| Q37122225 | Monocyte and macrophage heterogeneity in the heart |
| Q30418016 | Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes |
| Q42325772 | Monomeric C-reactive protein and inflammatory injury in myocardial infarction |
| Q35170119 | Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis |
| Q36545276 | Multimodal iron oxide nanoparticles for hybrid biomedical imaging |
| Q35375027 | Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice |
| Q90482425 | Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches |
| Q36456696 | Myocardial Infarction Causes Transient Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via gp130 |
| Q26999246 | Myocardial cell sheet therapy and cardiac function |
| Q58778850 | Myocardial expression of the anaphylatoxin receptor C3aR is associated with cardiac inflammation and prognosis in patients with non-ischaemic heart failure |
| Q41266798 | Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart |
| Q42362409 | Myocardial repair around-the-clock |
| Q38423887 | Myocardial tissue caveolae |
| Q38185647 | Myocyte signalling in leucocyte recruitment to the heart |
| Q41649704 | N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro. |
| Q49567423 | NADPH Oxidase-4 Driven Cardiac Macrophage Polarization Protects Against Myocardial Infarction-Induced Remodeling. |
| Q48155889 | Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed |
| Q37539910 | Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation |
| Q99717148 | Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages |
| Q38111517 | Neutrophil roles in left ventricular remodeling following myocardial infarction. |
| Q61808235 | Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence |
| Q64079516 | Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution? |
| Q55004726 | Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. |
| Q57176906 | New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types |
| Q38344492 | Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis |
| Q38440153 | Non-invasive Macrophage Tracking Using Novel Porphysome Nanoparticles in the Post-myocardial Infarction Murine Heart. |
| Q37662881 | Obese and diabetic KKAy mice show increased mortality but improved cardiac function following myocardial infarction. |
| Q42015792 | Optical projection tomography permits efficient assessment of infarct volume in the murine heart postmyocardial infarction |
| Q55070813 | Optimal intervention time of vagal stimulation attenuating myocardial ischemia/reperfusion injury in rats. |
| Q42368076 | Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells. |
| Q99549630 | Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action |
| Q47156777 | PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization. |
| Q37534751 | PEDF Inhibits the Activation of NLRP3 Inflammasome in Hypoxia Cardiomyocytes through PEDF Receptor/Phospholipase A2. |
| Q53060216 | PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction. |
| Q38596702 | Pathophysiology of Myocardial Infarction |
| Q38626782 | Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments. |
| Q41683277 | Pentraxin-3 regulates the inflammatory activity of macrophages |
| Q99408838 | Pericytes in the infarcted heart |
| Q42367648 | Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing |
| Q43760295 | Persistent Microvascular Obstruction After Myocardial Infarction Culminates in the Confluence of Ferric Iron Oxide Crystals, Proinflammatory Burden, and Adverse Remodeling |
| Q44385806 | Pinosylvin at a high concentration induces AMPK-mediated autophagy for preventing necrosis in bovine aortic endothelial cells |
| Q41240124 | Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury |
| Q100395007 | Porphyromonas gingivalis disrupts vascular endothelial homeostasis in a TLR-NF-κB axis dependent manner |
| Q38316469 | Post-myocardial infarct inflammation and the potential role of cell therapy |
| Q42152227 | Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation |
| Q90050163 | Pre-operative neutrophil-lymphocyte ratio predicts low cardiac output in children after cardiac surgery |
| Q41017955 | Preferred M2 Polarization by ASC-Based Hydrogel Accelerated Angiogenesis and Myogenesis in Volumetric Muscle Loss Rats |
| Q39070066 | Pro-inflammatory cytokines mediate GPCR dysfunction |
| Q34750686 | Proinflammatory effects and molecular mechanisms of interleukin-17 in intestinal epithelial cell line HT-29. |
| Q42561291 | Prostaglandin E2 in remote control of myocardial remodeling |
| Q33790719 | Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition. |
| Q37408448 | Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism |
| Q42732307 | Quantitation of acute necrosis after experimental myocardial infarction |
| Q62815342 | Rad GTPase deletion attenuates post-ischemic cardiac dysfunction and remodeling |
| Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
| Q38425473 | Recent advances in circadian rhythms in cardiovascular system |
| Q36936881 | Reconstitution of the myocardium in regenerating newt hearts is preceded by transient deposition of extracellular matrix components |
| Q37440555 | Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. |
| Q34356195 | Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function |
| Q35195128 | Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner |
| Q45789970 | Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis |
| Q37162037 | Renin inhibition improves the survival of mesenchymal stromal cells in a mouse model of myocardial infarction |
| Q92359410 | Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy |
| Q47165275 | Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation |
| Q41563819 | Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing |
| Q35744344 | Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. |
| Q50119083 | Role of Monocytes in Heart Failure and Atrial Fibrillation. |
| Q38206408 | Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction |
| Q42316685 | Role of microRNA-130a in myocardial hypoxia/reoxygenation injury |
| Q90644347 | SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome |
| Q36548318 | Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury |
| Q64094872 | Selectins and Immune Cells in Acute Myocardial Infarction and Post-infarction Ventricular Remodeling: Pathophysiology and Novel Treatments |
| Q60690194 | Simultaneous Assessment of Cardiac Inflammation and Extracellular Matrix Remodeling after Myocardial Infarction |
| Q42255247 | Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts |
| Q58127453 | Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis |
| Q90341456 | Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure |
| Q39018487 | Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38 |
| Q87981953 | Splenic leukocytes define the resolution of inflammation in heart failure |
| Q39549057 | Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli |
| Q27026285 | Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration |
| Q92501758 | Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction |
| Q58761419 | Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based |
| Q46244106 | Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction |
| Q55560176 | Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles. |
| Q37047650 | Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction |
| Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
| Q93069882 | TAM receptors in cardiovascular disease |
| Q37587563 | TNF-α regulates the proteolytic degradation of ST6Gal-1 and endothelial cell-cell junctions through upregulating expression of BACE1. |
| Q99593598 | Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-MI Remodeling |
| Q34125089 | Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling |
| Q90613619 | Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders |
| Q37100838 | Targeting inflammatory pathways in myocardial infarction. |
| Q27009347 | Targeting interleukin-1 in heart disease |
| Q26830555 | Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors |
| Q38120799 | Targeting the chemokines in cardiac repair. |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q43733452 | Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction |
| Q36702435 | Temporal neutrophil polarization following myocardial infarction |
| Q38875774 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. |
| Q38675294 | The Janus face of myofibroblasts in the remodeling heart |
| Q37733630 | The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation |
| Q28277713 | The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics |
| Q58749956 | The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the Heart |
| Q58700800 | The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction |
| Q53699115 | The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental? |
| Q89731961 | The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium |
| Q42368418 | The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation |
| Q39134471 | The Role of Inflammation in Cardiovascular Outcome. |
| Q89471537 | The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction |
| Q38995167 | The contribution of interleukin-2 to effective wound healing |
| Q38543648 | The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation--quo vadis? |
| Q36502326 | The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium |
| Q38254130 | The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. |
| Q38144845 | The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. |
| Q35529656 | The inflammatory response in myocardial injury, repair, and remodelling. |
| Q37161329 | The pathogenesis of cardiac fibrosis. |
| Q36399896 | The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction. |
| Q37139158 | The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair |
| Q38952244 | The role of cardiac fibroblasts in post-myocardial heart tissue repair |
| Q36204847 | The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation |
| Q38731483 | The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. |
| Q39265526 | The role of transforming growth factor (TGF)-β in the infarcted myocardium |
| Q37141384 | The time-of-day of myocardial infarction onset affects healing through oscillations in cardiac neutrophil recruitment |
| Q64066950 | The whole transcriptome and proteome changes in the early stage of myocardial infarction |
| Q44202532 | Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure |
| Q36479630 | Thrombospondins in the transition from myocardial infarction to heart failure. |
| Q44411568 | Tissue necrosis factor α and targeting its receptor in ischaemic heart disease |
| Q86486185 | To B or not to B--that is the question for myocardial infarction |
| Q35846211 | Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis |
| Q28541982 | Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension |
| Q38740286 | Topiramate modulates post-infarction inflammation primarily by targeting monocytes or macrophages |
| Q101138919 | Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair |
| Q27003127 | Use of mesenchymal stem cells for therapy of cardiac disease |
| Q37709242 | Using systems biology approaches to understand cardiac inflammation and extracellular matrix remodeling in the setting of myocardial infarction |
| Q37058562 | Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injury |
| Q37429699 | VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. |
| Q36225152 | Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction |
| Q41469937 | Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses |
| Q33755606 | Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury |
| Q92023843 | aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model |
| Q53321606 | mTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction. |
| Q38734588 | miR-181a and miR-150 regulate dendritic cell immune inflammatory responses and cardiomyocyte apoptosis via targeting JAK1-STAT1/c-Fos pathway |
Search more.